217 related articles for article (PubMed ID: 23523273)
21. Immunochemical studies in a patient with Waldenstrom's macroglobulinemia.
Mir-Ahmadian M; Rahbar S; Heidery H; Hajaliloo G
Acta Med Iran; 1978; 21(1):39-46. PubMed ID: 110036
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenström macroglobulinemia.
Muz B; de la Puente P; Azab F; Ghobrial IM; Azab AK
Mol Cancer Res; 2015 Feb; 13(2):263-72. PubMed ID: 25232031
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
[TBL] [Abstract][Full Text] [Related]
24. TCL1 expression patterns in Waldenström macroglobulinemia.
Lemal R; Bard-Sorel S; Montrieul L; Bay JO; Ravinet A; Ledoux-Pilon A; Cagnard N; Bailly S; Morel P; Charlotte F; Leleu X; Poulain S; Déchelotte PJ; Hermine O; Leblond V; Tournilhac O; Guièze R
Mod Pathol; 2016 Jan; 29(1):83-8. PubMed ID: 26493619
[TBL] [Abstract][Full Text] [Related]
25. [IgM myeloma. Apropos of a case].
Heron JF; Guaydier G; Loyau G; Laniece M; Mandart JC; Borel B; L'Hirondel JL; Dumas M; Foucault JP
Sem Hop; 1976 Dec; 52(44):2549-52. PubMed ID: 188198
[No Abstract] [Full Text] [Related]
26. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia.
Morice WG; Chen D; Kurtin PJ; Hanson CA; McPhail ED
Mod Pathol; 2009 Jun; 22(6):807-16. PubMed ID: 19287458
[TBL] [Abstract][Full Text] [Related]
27. Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-kappaB activation.
Merzianu M; Jiang L; Lin P; Wang X; Weber DM; Vadhan-Raj S; Nguyen MH; Medeiros LJ; Bueso-Ramos CE
Mod Pathol; 2006 Jul; 19(7):891-8. PubMed ID: 16636680
[TBL] [Abstract][Full Text] [Related]
28. Functional studies on B cells in human bone marrow: in vitro mitogen stimulation of normal and malignant B cells.
Hammarstróm L; Smith CI; Pettersson D; Mellstedt H; Holm G
Clin Exp Immunol; 1981 Jan; 43(1):157-64. PubMed ID: 6788412
[TBL] [Abstract][Full Text] [Related]
29. Clinical, Laboratory, and Bone Marrow Findings of 31 Patients With Waldenström Macroglobulinemia.
Ahn A; Park CJ; Cho YU; Jang S; Seo EJ; Lee JH; Yoon DH; Suh C
Ann Lab Med; 2020 May; 40(3):193-200. PubMed ID: 31858758
[TBL] [Abstract][Full Text] [Related]
30. [Waldenström macroglobulinemia].
Telek B; Batár P; Váróczy L; Gergely L; Rejtő L; Szász R; Miltényi Z; Simon Z; Udvardy M; Illés A
Orv Hetil; 2013 Dec; 154(50):1970-4. PubMed ID: 24317355
[TBL] [Abstract][Full Text] [Related]
31. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
32. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia.
Treon SP; Agus TB; Link B; Rodrigues G; Molina A; Lacy MQ; Fisher DC; Emmanouilides C; Richards AI; Clark B; Lucas MS; Schlossman R; Schenkein D; Lin B; Kimby E; Anderson KC; Byrd JC
J Immunother; 2001; 24(3):272-9. PubMed ID: 11394506
[TBL] [Abstract][Full Text] [Related]
33. Atypical chronic lymphocytic leukemia presenting with massive IgM paraprotein.
Tachiki L; Dong ZM; Burwick N
Ann Hematol; 2018 May; 97(5):921-922. PubMed ID: 29411125
[No Abstract] [Full Text] [Related]
34. Immunophenotypic features by multiparameter flow cytometry can help distinguish low grade B-cell lymphomas with plasmacytic differentiation from plasma cell proliferative disorders with an unrelated clonal B-cell process.
Rosado FG; Morice WG; He R; Howard MT; Timm M; McPhail ED
Br J Haematol; 2015 May; 169(3):368-76. PubMed ID: 25644063
[TBL] [Abstract][Full Text] [Related]
35. Waldenström macroglobulinemia.
Treon SP; Hunter ZR; Castillo JJ; Merlini G
Hematol Oncol Clin North Am; 2014 Oct; 28(5):945-70. PubMed ID: 25212891
[TBL] [Abstract][Full Text] [Related]
36. [Waldenström macroglobulinemia associated with cutaneous lesions and type I cryoglobulinemia].
del Olmo J; España A; Idoate MA; Panizo C
Actas Dermosifiliogr; 2008 Mar; 99(2):138-44. PubMed ID: 18346436
[TBL] [Abstract][Full Text] [Related]
37. Tumoral macroglobulinosis of the skin: In situ release of IgM.
Bonnetblanc JM; Bedane C; Fayol J; Labrousse F
Acta Derm Venereol; 2006; 86(1):63-4. PubMed ID: 16585994
[No Abstract] [Full Text] [Related]
38. Immunofluorescence studies in Waldenström's macroglobulinemia.
Preud'homme JL; Hurez D; Seligmann M
Rev Eur Etud Clin Biol; 1970 Dec; 15(10):1127-31. PubMed ID: 4996339
[No Abstract] [Full Text] [Related]
39. CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.
Olteanu H; Harrington AM; Kroft SH
Am J Clin Pathol; 2012 Dec; 138(6):867-76. PubMed ID: 23161721
[TBL] [Abstract][Full Text] [Related]
40. Waldenström macroglobulinemia: from biology to treatment.
Sahin I; Leblebjian H; Treon SP; Ghobrial IM
Expert Rev Hematol; 2014 Feb; 7(1):157-68. PubMed ID: 24405328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
